1. Home
  2. LCID vs MLTX Comparison

LCID vs MLTX Comparison

Compare LCID & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lucid Group Inc.

LCID

Lucid Group Inc.

HOLD

Current Price

$7.45

Market Cap

2.0B

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$19.76

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCID
MLTX
Founded
2007
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
LCID
MLTX
Price
$7.45
$19.76
Analyst Decision
Hold
Buy
Analyst Count
7
12
Target Price
$15.71
$27.50
AVG Volume (30 Days)
19.9M
1.5M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$595,271,000.00
N/A
Revenue This Year
$71.67
N/A
Revenue Next Year
$89.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.97
$5.95
52 Week High
$25.22
$62.75

Technical Indicators

Market Signals
Indicator
LCID
MLTX
Relative Strength Index (RSI) 63.72 52.93
Support Level $5.59 $15.89
Resistance Level $10.79 $21.14
Average True Range (ATR) 0.90 0.91
MACD 0.13 -0.07
Stochastic Oscillator 97.78 46.10

Price Performance

Historical Comparison
LCID
MLTX

About LCID Lucid Group Inc.

Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It offers its own geographically distributed retail and service locations through direct-to-consumer online and retail sales. It also boasts a product roadmap of future vehicle programs and technologies. It focuses on in-house hardware and software innovation, vertical integration, and a clean-sheet approach to engineering and design, which led to the development of the Lucid Air. The Lucid Air is a luxury sedan that redefines both the luxury car segment and the EV space. Its geographic segments include North America, the Middle East, and Other International.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: